The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 07, 2026
Filed:
Feb. 03, 2025
Applicant:
Viiv Healthcare Uk (No.5) Limited, Stevenage, GB;
Inventors:
Manoj Patel, Branford, CT (US);
Kyle E. Parcella, Branford, CT (US);
Eric P. Gillis, Branford, CT (US);
B Narasimhulu Naidu, Branford, CT (US);
Assignee:
ViiV Healthcare UK (No. 5) Limited, Stevenage, GB;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 31/439 (2006.01); A61K 31/4402 (2006.01); A61K 31/4439 (2006.01); A61K 31/4985 (2006.01); A61K 31/505 (2006.01); A61K 31/513 (2006.01); A61K 31/5365 (2006.01); A61K 31/5377 (2006.01); A61K 31/635 (2006.01); A61K 31/675 (2006.01); A61P 31/18 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/439 (2013.01); A61K 31/4402 (2013.01); A61K 31/4439 (2013.01); A61K 31/4985 (2013.01); A61K 31/505 (2013.01); A61K 31/513 (2013.01); A61K 31/5365 (2013.01); A61K 31/5377 (2013.01); A61K 31/635 (2013.01); A61K 31/675 (2013.01); A61P 31/18 (2018.01); C07D 471/04 (2013.01);
Abstract
A compound of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treatment or prevention of human immunodeficiency virus (HIV) infection are set forth. Novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection are described. Formula (I) is as follows: